Nerve growth factor: A focus on neuroscience and therapy

Current Neuropharmacology

Volumn 13, Issue 3, 2015, Pages 294-303

  Aloe, Luigi ^a   Rocco, Maria Luisa ^a   Balzamino, Bijorn Omar ^b   Micera, Alessandra ^b  

^a CNR   (Italy)

^b IRCCS FONDAZIONE BIETTI   (Italy)

Author keywords

Clinical trials; NGF; NGF receptors; NGF healing action; Treatment; Visual system

Indexed keywords

NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; NGF PROTEIN, HUMAN;

ARTICLE; BIOLOGICAL ACTIVITY; CENTRAL NERVOUS SYSTEM FUNCTION; CLINICAL TRIAL (TOPIC); CORNEA ULCER; DECUBITUS; DIABETIC RETINOPATHY; GLAUCOMA; HUMAN; IMMUNE SYSTEM; NEURITIS; NEUROSCIENCE; PERIPHERAL NERVOUS SYSTEM FUNCTION; RETINA MACULOPATHY; RETINITIS PIGMENTOSA; TREATMENT OUTCOME; VISUAL SYSTEM FUNCTION; ANIMAL; METABOLISM; NERVE CELL;

ANIMALS; CLINICAL TRIALS AS TOPIC; CORNEAL ULCER; HUMANS; NERVE GROWTH FACTOR; NEURONS; NEUROSCIENCES; RECEPTORS, NERVE GROWTH FACTOR;

EID: 84938701806     PISSN: 1570159X     EISSN: 18756190     Source Type: Journal    
DOI: 10.2174/1570159X13666150403231920     Document Type: Article

References (97)

1. [1] Levi-Montalcini, R. The nerve growth factor 35 years later. Science, 1987, 237, 1154-1162. http://dx.doi.org/10.1126/science.3306916
2. [2] Aloe, L., Calzà, L. NGF and Related Molecules in Health and Disease. Prog. Brain Res., 2004, 146. Elsevier Editor.
3. [3] Reichardt, L.F. Neurotrophin-regulated signaling pathways. Philos. Trans. R. Soc. Lond. B. Biol. Sci., 2006, 361, 1545-1564. http://dx.doi.org/10.1098/rstb.2006.1894
4. [4] Huang, E.J., Reichardt, L.F. TRK receptors: roles in neuronal signal transduction. Annu. Rev. Biochem., 2003, 72, 609-642. http://dx.doi.org/10.1146/annurev.biochem.72.121801.161629
5. [5] Sofroniew, M.V., Howe, C.L., Mobley, W.C. Nerve growth factor signaling neuroprotection, and neural repair. Ann. Rev. Neurosci., 2001, 24, 1217-1281. http://dx.doi.org/10.1146/annurev.neuro.24.1.1217
6. [6] Ebendal, T. Function and evolution in the NGF family and its receptors. J. Neurosci. Res., 1992, 32, 461-470. http://dx.doi.org/10.1002/jnr.490320402
7. [7] Micera, A., Lambiase, A., Stampachiacchiere, B., Bonini, S., Bonini, S., Levi-Schaffer, F. Nerve growth factor and tissue repair remodeling: trkA(NGFR) and p75(NTR), two receptors one fate. Cytokine Growth Factor Rev., 2007, 18, 245-256. http://dx.doi.org/10.1016/j.cytogfr.2007.04.004
8. [8] Hellweg, R., Raivich, G., Hartung, H.D., Hock, C., Kreutzberg, G.W. Axonal transport of endogenous nerve growth factor (NGF) and NGF receptor in experimental diabetic neuropathy. Exp. Neurol., 1994, 130, 24-30. http://dx.doi.org/10.1006/exnr.1994.1181
9. [9] Apfel, S.C., Kessler, J.A. Neurotrophic factors in the therapy of peripheral neuropathy. Baillieres Clin. Neurol., 1995, 4, 593-606.
10. [10] Riaz, S.S., Tomlinson, D.R. Neurotrophic factors in peripheral neuropathies: pharmacological strategies. Prog. Neurobiol., 1996, 49, 125-143. http://dx.doi.org/10.1016/0301-0082(96)00010-X
11. [11] McMahon, S.B., Priestley, J.V. Peripheral neuropathies and neurotrophic factors: animal models and clinical perspectives. Curr. Opin. Neurobiol., 1995, 5, 616-624. http://dx.doi.org/10.1016/0959-4388(95)80067-0
12. [12] Apfel, S.C. Nerve growth factor for the treatment of diabetic neuropathy: what went wrong, what went right, and what does the future hold? Int. Rev. Neurobiol., 2002, 50, 393-413. http://dx.doi.org/10.1016/s0074-7742(02)50083-0
13. [13] Lambiase, A., Rama, P., Bonini, S., Caprioglio, G., Aloe, L. Topical treatment with nerve growth factor for corneal neurotrophic ulcers. N. Engl. J. Med., 1998, 338, 1174-1180. http://dx.doi.org/10.1056/NEJM199804233381702
14. [14] Lambiase, A., Aloe, L., Centofanti, M., Parisi, V., Mantelli, F., Colafrancesco, V., Manni, G.L., Bucci, M.G., Bonini, S., Levi-Montalcini, R. Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucoma. Proc. Natl. Acad. Sci. USA, 2009, 106, 13469-13474. http://dx.doi.org/10.1073/pnas.0906678106
15. [15] Lambiase, A., Manni, L., Bonini, S., Mantelli, F., Aloe, L. Nerve growth factor eye drops improve visual acuity and electro functional activity in age-related macular degeneration: a case report. Ann. Ist. Super. Sanità, 2009, 45, 439-442. http://dx.doi.org/10.1590/S0021-25712009000400014
16. [16] Lenzi, L., Coassin, M., Lambiase, A., Bonini, S., Amendola, T., Aloe, L. Effect of exogenous administration of nerve growth factor in the retina of rats with inherited retinitis pigmentosa. Vision Res., 2005, 45, 1491-1500. http://dx.doi.org/10.1016/j.visres.2004.12.020
17. [17] Lambiase, A., Coassin, M., Sposato V., Micera, A., Sacchetti, M., Bonini, S., Aloe, L. NGF topical application in patients with corneal ulcers does not generate circulating NGF antibodies. Pharmacol. Res., 2007, 56, 65-69. http://dx.doi.org/10.1016/j.visres.2004.12.020
18. [18] Ferrari, M.P., Mantelli, F., Sacchetti, M., Antonangeli, M.I., Cattani, F., D'Anniballe, G., Sinigaglia, F., Ruffini, P.A., Lambiase, A. Safety and Pharmacokinetics of Escalating Doses of Human Recombinant Nerve Growth Factor Eye Drops in a Double-Masked, Randomized Clinical Trial. BioDrugs, 2014, 28, 275-283. http://dx.doi.org/10.1007/s40259-013-0079-5
19. [19] Micera, A., Puxeddu, I., Aloe, L., Levi-Schaffer, F. New insights on the involvement of Nerve Growth Factor in allergic inflammation and fibrosis. Cytokine Growth Factor Rev., 2003, 14, 369-374. http://dx.doi.org/10.1016/S1359-6101(03)00047-9
20. [20] Lambiase, A., Micera, A., Sgrulletta, R., Bonini, S., Bonini, S. Nerve growth factor and the immune system: old and new concepts in the cross-talk between immune and resident cells during pathophysiological conditions. Curr. Opin. Allergy Clin. Immunol., 2004, 4, 425-430. http://dx.doi.org/10.1097/00130832-200410000-00015
21. [21] Matsuda, H., Koyama, H., Sato, H., Sawada, J., Itakura, A., Tanaka, A., Matsumoto, M., Konno, K., Ushio, H., Matsuda, K. Role of nerve growth factor in cutaneous wound healing: accelerating effects in normal and healing-impaired diabetic mice. J. Exp. Med., 1998, 187, 297-306. http://dx.doi.org/10.1084/jem.187.3.297
22. [22] Bernabei, R., Landi, F., Bonini, S, Onder, G., Lambiase, A., Pola, R., Aloe, L. Effect of topical application of nerve-growth factor on pressure ulcers. Lancet, 1999, 354, 307. http://dx.doi.org/10.1016/S0140-6736(99)02784-1
23. [23] Landi, F., Aloe, L., Russo, A., Cesari, M., Onder, G., Bonini, S., Carbonin, P.U., Bernabei, R. Topical treatment of pressure ulcers with nerve growth factor: a randomized clinical trial. Ann. Intern. Med., 2003 139, 635-641. http://dx.doi.org/10.7326/0003-4819-139-8-200310210-00006
24. [24] Aloe, L., Tirassa, P., Lambiase, A. The topical application of nerve growth factor as a pharmacological tool for human corneal and skin ulcers. Pharmacol. Res., 2008, 57, 253-258. http://dx.doi.org/10.1016/j.phrs.2008.01.010
25. [25] Micera, A., Vigneti, E., Pickholtz, D., Reich, R., Pappo, O., Bonini, S., Maquart, F.X., Aloe, L., Levi-Schaffer, F. Nerve growth factor displays stimulatory effects on human skin and lung fibroblasts, demonstrating a direct role for this factor in tissue repair. Proc. Natl. Acad. Sci. U.S.A. 2001 98, 6162-6167. http://dx.doi.org/10.1073/pnas.101130898
26. [26] Lambiase, A., Aloe, L., Mantelli, F., Sacchetti, M., Perrella, E., Bianchi, P., Rocco, M.L., Bonini, S. Capsaicin-Induced Corneal Sensory Denervation and Healing Impairment Are Reversed by NGF Treatment. Invest. Ophthalmol. Vis. Sci., 2012, 53, 8280-8287. http://dx.doi.org/10.1167/iovs.12-10593
27. [27] Micera, A., Puxeddu, I., Balzamino, B.O., Bonini, S., Levi-Schaffer, F. Chronic nerve growth factor exposure increases apoptosis in a model of in vitro induced conjunctival myofibroblasts. PLoS One, 2012, 7, e47316. http://dx.doi.org/10.1371/journal.pone.0047316
28. [28] Oakley, F., Trim, N., Constandinou, C.M., Ye, W., Gray, A.M., Frantz, G., Hillan, K., Kendall, T., Benyon, R.C., Mann, D.A., Iredale, J.P. Hepatocytes express nerve growth factor during liver injury: evidence for paracrine regulation of hepatic stellate cell apoptosis. Am. J. Pathol., 2003, 163, 1849-1858. http://dx.doi.org/10.1016/S0002-9440(10)63544-4
29. [29] Trim, N., Morgan, S., Evans, M., Issa, R., Fine, D., Afford, S., Wilkins, B., Iredale, J. Hepatic stellate cells express the low affinity nerve growth factor receptor p75 and undergo apoptosis in response to nerve growth factor stimulation. Am. J. Pathol., 2000, 156, 1235-1243. http://dx.doi.org/10.1016/S0002-9440(10)64994-2
30. [30] Kaur, H., Chaurasia, S.S., Agrawal, V., Suto, C., Wilson, S.E. Corneal myofibroblast viability: opposing effects of IL-1 and TGF beta1. Exp. Eye. Res., 2009, 89, 152-158. http://dx.doi.org/10.1016/j.exer.2009.03.001
31. [31] Lindsay, R.M., Harmar, A.J. Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurons. Nature, 1989, 337, 362-364. http://dx.doi.org/10.1038/337362a0
32. [32] Verge, V.M., Richardson, P.M., Wiesenfeld-Hallin, Z., Hokfelt, T. Differential influence of nerve growth factor on neuropeptide expression in vivo: a novel role in peptide suppression in adult sensory neurons. J. Neurosci., 1995, 15, 2081-2096.
33. [33] Otten, U., Schwab, M., Gagnon, C., Thoenen, H. Selective induction of tyrosine hydroxylase and dopamine beta-hydroxylase by nerve growth factor comparison between adrenal medulla and sympathetic ganglia of adult and newborn rats. Brain Res., 1977, 133, 291-303. http://dx.doi.org/10.1016/0006-8993(77)90765-X
34. [34] Apfel, S.C., Kessler, J.A., Adornato, B.T., Litchy, W.J., Sanders, C., Rask, C.A. Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. NGF Study Group. Neurology., 1998, 51, 695-702. http://dx.doi.org/10.1212/WNL.51.3.695
35. [35] Apfel, S.C. Neurotrophic factors in the therapy of diabetic neuropathy. Am. J. Med., 1999, 107, 34S-42S. http://dx.doi.org/10.1016/S0002-9343(99)00011-X
36. [36] McArthur J.C., Yiannoutsos, C., Simpson, D.M., Adornato, B.T., Singer, E.J., Hollander, H., Marra, C., Rubin, M., Cohen, B.A., Tucker, T., Navia, B.A., Schifitto, G., Katzenstein, D., Rask, C., Zaborski, L., Smith, M.E., Shriver, S., Millar, L., Clifford, D.B., Karalnik, I.J. A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection. AIDS Clinical Trials Group Team 291. Neurology, 2000, 54, 1080-1088.
37. [37] Connor, B., Dragunow, M. The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res. Brain Res. Rev., 1998, 27, 1-39. http://dx.doi.org/10.1016/S0165-0173(98)00004-6
38. [38] McAllister, A.K., Neurotrophins and neuronal differentiation in the central nervous system. Cell. Mol. Life Sci., 2001, 58, 1054-1060. http://dx.doi.org/10.1007/PL00000920
39. [39] Dreyfus, C.F. Effects of nerve growth factor on cholinergic brain neurons. Trends Pharmacol. Sci., 1989, 10, 145-149. http://dx.doi.org/10.1016/0165-6147(89)90166-1
40. [40] Backman, C., Rose, G.M., Hoffer, B.J., Henry, M.A., Barlus, R.T., Friden, P., Granholm A.C. Systemic administration of a nerve growth factor conjugate reverses age-related cognitive dysfunction and prevents cholinergic neuron atrophy. J. Neurosci., 1996, 16, 5437-5442.
41. [41] Fischer W, Wictorin K, Björklund A, Williams LR, Varon S, Gage FH. Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature. 1987, 329, 65-68. http://dx.doi.org/10.1038/329065a0
42. [42] Eriksdotter Jonhagen, M., Nordberg, A., Amberla, K., Backman, L., Ebendal, T., Meyerson, B., Olson, L., Seiger, Shigeta, M., Theodorsson, E., Viitanen, M., Winblad, B., Wahlund, L.O. Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease. Dement Geriatr. Cogn. Disord., 1998, 9, 246-257. http://dx.doi.org/10.1159/000017069
43. [43] Tuszynski, M.H., Thal, L., Pay, M., Salmon, D.P., UH, S., Bakay, R., Patel, P., Blesch, A., Vahlsing, H.L., Ho, G., Tong, G., Potkin, S.G., Fallon, J., Hansen, L., Mufson, E.J., Kordower, J.H., Gall, C., Conner, J. A phase 1 clinical trial of nerve growth factor Alzheimer’s disease for Alzheimer disease. Nat. Med., 2005, 11, 551-555. http://dx.doi.org/10.1038/nm1239
44. [44] Granholm, A.C., Bäckman, C., Bloom, F., Ebendal, T., Gerhardt, G.A., Hoffer, B., Mackerlova, L., Olson, L., Söderström, S., Walus, L.R., et al. NGF and anti-transferrin receptor antibody conjugate: short and long-term effects on survival of cholinergic neurons in intraocular septal transplants. J. Pharmacol. Exp. Ther., 1994, 268, 448-459. http://dx.doi.org/10.1515/REVNEURO.1998.9.1.31
45. [45] Granholm, A.C., Albeck, D., Bäckman, C., Curtis, M., Ebendal, T., Friden, P., Henry, M., Hoffer, B., Kordower, J., Rose, G.M., Söderström, S., Bartus, R.T. A non-invasive system for delivering neural growth factors across the blood brain barries: a review. Rev. Neurosci., 1998, 9, 31-55. http://dx.doi.org/10.1515/REVNEURO.1998.9.1.31
46. [46] Thorne RG, Emory CR, Ala TA, Frey WH 2nd.Quantitative analysis of the olfactory pathway for drug delivery to the brain. Brain Res., 1995, 692, 278-282. http://dx.doi.org/10.1016/0006-8993(95)00637-6
47. [47] Illum, L., Transport of drugs from the nasal cavity to the central nervous system. Eur. J. Pharm. Sci., 2000, 11, 1-18. http://dx.doi.org/10.1016/S0928-0987(00)00087-7
48. [48] Chen, X.Q., Fawcett, J.R., Rahman, Y.E., Ala, T.A., Frey, W.H. Delivery of Nerve Growth Factor to the Brain via the Olfactory Pathway. J. Alzheimers Dis., 1998, 1, 35-44.
49. [49] Di Fausto, V., Fiore, M., Tirassa, P., Lambiase, A., Aloe, L. Eye drop NGF administration promotes the recovery of chemically injured cholinergic neurons of adult mouse forebrain. Eur. J. Neurosci., 2007, 26, 2473-2480. http://dx.doi.org/10.1111/j.1460-9568.2007.05883.x
50. [50] Miwa, T., Moriizumi, T., Horikawa, I., Uramoto, N., Ishimaru, T., Nishimura, T., Furukawa, M. Role of nerve growth factor in the olfactory system. Microsc. Res. Tech., 2002, 58, 197-203. http://dx.doi.org/10.1002/jemt.10149
51. [51] Vaka, S.R., Murthy, S.N., Balaji, A., Repka, M.A. Delivery of brain-derived neurotrophic factor via nose-to-brain pathway. Pharm. Res., 2001, 29, 441-447. http://dx.doi.org/10.1007/s11095-011-0572-9
52. [52] Micera, A., Lambiase, A., Aloe, L., Bonini, S., Levi-Schaffer, F., Bonini, S. Nerve growth factor involvement in the visual system: implications in allergic and neurodegenerative diseases. Cytokine Growth Factor Rev., 2004, 15, 411-417. http://dx.doi.org/10.1016/j.cytogfr.2004.09.003
53. [53] You, L., Kruse, F.E., Völcker, H.E. Neurotrophic factors in the human cornea. Invest. Ophthalmol. Vis. Sci., 2000, 41, 692-702.
54. [54] Lambiase, A., Manni, L., Bonini, S., Rama, P., Micera, A., Aloe L. Nerve growth factor promotes corneal healing: structural, biochemical and molecular analysis of rat and human corneas. Invest. Ophthalmol. Vis. Sci., 2000, 41, 1063-1069.
55. [55] Lambiase, A., Tirassa, P., Micera, A., Aloe, L., Bonini, S. Pharmacokinetics of conjunctivally applied nerve growth factor in the retina and optic nerve of adult rats. Invest. Olhthalmol. Vis. Sci., 2005, 46, 3008-3006. http://dx.doi.org/10.1167/iovs.05-0301
56. [56] Muller, L.J., Marfurt, C.F., Kruse, F., Tervo, T.M. Corneal nerves: structure, contents and function. Exp. Eye. Res., 2003, 76, 521-542. http://dx.doi.org/10.1016/S0014-4835(03)00050-2
57. [57] Lambiase, A., Manni, L., Bonini, S., Rama, P., Micera, A., Aloe, L. Nerve growth factor promotes corneal healing: structural, biochemical, and molecular analyses of rat and human corneas. Invest.Ophthalmol. Vis. Sci. 2000 1, 1063-1069.
58. [58] Lambiase, A., Micera, A., Pellegrini, G., Merlo, D., Rama, P., De Luca, M., Bonini, S., Bonini, S. In vitro evidence of nerve growth factor effects on human conjunctival epithelial cell differentiation and mucin gene expression. Invest. Ophthalmol. Vis. Sci., 2009, 50, 4622-4630. http://dx.doi.org/10.1167/iovs.08-2716
59. [59] Micera, A., Lambiase, A., Puxeddu, I., Aloe, L., Stampachiacchiere, B., Levi-Schaffer, F., Bonini, S., Bonini, S. Nerve growth factor effect on human primary fibroblastickeratocytes: possible mechanism during corneal healing. Exp. Eye. Res., 2006, 83, 747-757. http://dx.doi.org/10.1016/j.exer.2006.03.010
60. [60] Micera, A., Puxeddu, I., Lambiase, A., Antonelli, A., Bonini, S., Bonini, S., Aloe, L., Pe'er, J., Levi-Schaffer, F. The pro-fibrogenic effect of nerve growth factor on conjunctival fibroblasts is mediated by transforming growth factor-beta. Clin. Exp. Allergy., 2005, 35, 650-656. http://dx.doi.org/10.1111/j.1365-2222.2005. 02241.x
61. [61] Sornelli, F., Lambiase, A., Mantelli, F., Aloe, L. NGF and NGFreceptor expression of cultured immortalized human corneal endothelial cells. Mol. Vis., 2010, 16, 1439-1447.
62. [62] Coassin M., Lambiase, A., Costa, N., De Gregorio, A., Sgrulletta, R., Sacchetti, M., Aloe, L., Bonini, S. Efficacy of topical nerve growth factor treatment in dogs affected by dry eye. Graefes Arch. Clin. Exp. Ophthalmol., 2005, 243, 151-155. http://dx.doi.org/10.1007/s00417-004-0955-2
63. [63] Generini, S., Tuveri, M.A., Matucci Cerinic, M., Mastinu, F., Manni, L., Aloe, L. Topical application of nerve growth factor in human diabetic foot ulcers. A study of three cases. Exp. Clin. Endocrinol. Diabetes, 2004, 112, 542-544. http://dx.doi.org/10.1055/s-2004-821313
64. [64] Tuveri, M., Generini, S., Matucci-Cerinic, M., Aloe, L. NGF, a useful tool in the treatment of chronic vasculitic ulcers in rheumatoid arthritis. Lancet, 2000, 356, 1739-1740. http://dx.doi.org/10.1016/S0140-6736(00)03212-8
65. [65] Costa, N., Fiore, M., Aloe, L. Healing action of nerve growth factor on lameness in adult goats. Ann. Ist. Super. Sanità, 2002, 38, 187-194.
66. [66] Turner, J. E., Delaney, R. K., Retinal ganglion cell response to axotomy and nerve growth factor in the regenerating visual system of the newt (notophthalmus viridiscens): an ultrastructural morphometric analysis, Brain Res., 1979, 171, 197-212. http://dx.doi.org/10.1016/0006-8993(79)90327-5
67. [67] Maffei, L., Berardi, N., Domenici, L., Parisi, V., Pizzorusso, T. Nerve growth factor (NGF) prevents the shift in ocular dominance distribution of visual cortical neurons in monocularly deprived rats. J. Neurosci., 1992, 12, 4651-4662.
68. [68] Siliprandi, R., Canella, R., Carmignoto, G. Nerve growth factor promotes functional recovery of retinal ganglion cells after ischemia, Invest. Ophthalmol. Vis. Sci., 1993, 34, 3232-3245.
69. [69] Carmignoto, G., Maffei, L., Candeo, P., Canella, R., Comelli, C. Effect of NGF on the survival of rat retinal ganglion cells following optic nerve section. J. Neurosci., 1989, 9, 1263-1272.
70. [70] Domenici, L., Berardi, N., Carmignoto, G., Vantini, G., Maffei, L. Nerve growth factor prevents the amblyopic effects of monocular deprivation. Proc. Natl. Acad. Sci. USA, 1991, 88, 8811-8815. http://dx.doi.org/10.1073/pnas.88.19.8811
71. [71] Domenici, L., Cellerino, A., Berardi, N., Cattaneo, A., Maffei, L. Antibodies to nerve growth factor (NGF) prolong the sensitive period for monocular deprivation in the rat. Neuroreport, 1994, 5, 2041-2044. http://dx.doi.org/10.1097/00001756-199410270-00013
72. [72] Lambiase, A., Centofanti, M., Micera, A., Manni, G.L., Mattei, E., De Gregorio, A., de Feo, G., Bucci, M.G., Aloe, L. Nerve growth factor (NGF) reduces and NGF antibody exacerbates retinal damage induced in rabbit by experimental ocular hypertension. Graefes Arch. Clin. Exp. Ophthalmol., 1997, 235, 780-785. http://dx.doi.org/10.1007/BF02332863
73. [73] Micera, A., Lambiase, A., Rama, P., Aloe, L. Altered nerve growth factor level in the optic nerve of patients affected by multiple sclerosis. Mult. Scler., 1999, 5, 389-394. http://dx.doi.org/10.1177/135245859900500i604
74. [74] Quigley, H.A. Number of people with glaucoma worldwide. Br. J. Ophthalmol., 1996, 80, 389-393. http://dx.doi.org/10.1136/bjo.80. 5.389
75. [75] Kingman, S. Glaucoma is second leading cause of blindness globally. Bull. World Health Organ., 2004, 82, 887-888.
76. [76] Morrison, J.C., Moore, C.G., Deppmeier, L.M., Gold, B.G., Meshul, C.K., Johnson, E.C. A rat model of chronic pressureinduced optic nerve damage. Exp. Eye. Res., 1997, 64, 85-96. http://dx.doi.org/10.1006/exer.1996.0184
77. [77] Sposato, V., Bucci, M.G., Coassin, M., Russo, M.A., Lambiase, A., Aloe, L. Reduced NGF level and TrkA protein and TrkA gene expression in the optic nerve of rats with experimentally induced glaucoma. Neurosci. Lett., 2008, 446, 20-24. http://dx.doi.org/10.1016/j.neulet.2008.09.024
78. [78] Sposato, V., Parisi, V., Manni, L., Antonucci, M.T., Di Fausto, V., Sornelli, F., Aloe, L. Glaucoma alters the expression of NGF and NGF receptors in visual cortex and geniculate nucleus of rats: effect of eye NGF application. Vision Res., 2009, 49, 54-63. http://dx.doi.org/10.1016/j.visres.2008.09.024
79. [79] Faktorovich, E.G., Steinberg, R.H., Yasumura, D., Matthes, M.T., LaVail, M.M. Photoreceptor degeneration in inherited retinal dystrophy delayed by basic fibroblast growth factor. Nature. 1990, 347, 83-86. http://dx.doi.org/10.1038/347083a0
80. [80] Busskamp, V., Picaud, S., Sahel, J.A., Roska, B. Optogenetic therapy for retinitis pigmentosa. Gene Ther., 2012, 19, 169-175. http://dx.doi.org/10.1038/gt.2011.155
81. [81] Jacobson, S.G., Cideciyan, A.V. Treatment possibilities for retinitis pigmentosa. N. Engl. J. Med., 2010, 363, 1669-1671. http://dx.doi.org/10.1056/NEJMcibr1007685
82. [82] Lambiase, A., Aloe, L. Nerve growth factor delays retinal degeneration in C3H mice. Graefe’s Arch. Clin. Exp. Ophthalmol., 1996, 234, S96-100. http://dx.doi.org/10.1007/BF02343055
83. [83] Amendola, T., Aloe, L. Developmental expression of nerve growth factor in the eye of rats affected by inherited retinopathy: correlative aspects with retinal structural degeneration. Arch. Ital. Biol, 2002, 140, 81-90.
84. [84] Amendola, T., Fiore, M., Aloe, L. Postnatal changes in nerve growth factor and brain derived neurotrophic factor levels in the retina, visual cortex and geniculate. Arch. Ital. Biol, 2003, 345, 37-40.
85. [85] Yuan, D., Yuan, D., Yuan, S., Liu, Q. The age-related maculopathy susceptibility 2 polymorphism and polypoidal choroidal vasculopathy in Asian populations: a meta-analysis. Ophthalmology, 2013, 120, 2051-2057. http://dx.doi.org/10.1016/j.ophtha.2013.03.026
86. [86] Jager, R.D., Mieler, W.F., Miller, J.W. Age-related macular degeneration. N. Engl. J. Med., 2008, 358, 2606-2617. http://dx.doi.org/10.1056/NEJMra0801537
87. [87] Antonetti, D.A., Klein, R., Gardner, T.W. Diabetic retinopathy. N. Engl. J. Med., 2012, 366, 1227-1239. http://dx.doi.org/10.1056/NEJMra1005073
88. [88] Hammes, H.P., Federoff, H.J., Brownlee, M. Nerve growth factor prevents both neuroretinal programmed cell death and capillary pathology in experimental diabetes. Mol Med., 1995, 1, 527-534.
89. [89] Mantelli, F., Lambiase, A., Colafrancesco, V., Rocco, M.L., Macchi, I., Aloe, L. NGF and VEGF effects on retinal ganglion cell fate: new evidence from an animal model of diabetes. Eur. J. Ophthalmol., 2014, 24, 247-253. http://dx.doi.org/10.5301/ejo. 5000359
90. [90] Sondell, M., Sundler, F., Kanje, M. Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk-1 receptor. Eur. J. Neurosci., 2000, 12, 4243-4254. http://dx.doi.org/10.1046/j.0953-816X.2000.01326.x
91. [91] Nishijima, K., Ng, Y.S., Zhong, L., Bradley, J., Schubert, W., Jo, N., Akita, J., Samuelsson, S.J., Robinson, G.S., Adamis, A.P., Shima, D.T. Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. Am. J. Pathol., 2007, 171, 53-67. http://dx.doi.org/10.2353/ajpath.2007.061237
92. [92] Whitmire, W., Al-Gayyar, M.M., Abdelsaid, M., Yousufzai, B.K., El-Remessy, A.B. Alteration of growth factors and neuronal death in diabetic retinopathy: what we have learned so far. Mol. Vis., 2011, 17, 300-308.
93. [93] Abe, T., Morgan, D.A., Gutterman, D.D. Protective role of nerve growth factor against postischemic dysfunction of sympathetic coronary innervation. Circulation. 1997, 95, 213-220. http://dx.doi.org/10.1161/01.CIR.95.1.213
94. [94] Holtzman, D.M., Sheldon, R.A., Jaffe, W., Cheng, Y., Ferriero, D.M. Nerve growth factor protects the neonatal brain against hypoxic-ischemic injury. Ann. Neurol. 1996, 39, 114-122. http://dx.doi.org/10.1002/ana.410390117
95. [95] Villoslada, P., Genain, C.P. Role of nerve growth factor and other trophic factors in brain inflammation. Prog. Brain Res. 2004, 146, 403-414. http://dx.doi.org/10.1016/s0079-6123(03)46025-1
96. [96] Kaye, D.M., Vaddadi, G., Gruskin, S.L., Du, X.J., Esler, M.D. Reduced myocardial nerve growth factor expression in human and experimental heart failure. Circ. Res., 2000, 86, E80-84. http://dx.doi.org/10.1161/01.RES.86.7.e80
97. [97] Chiaretti, A., Falsini, B., Aloe, L., Pierri, F., Fantacci, C., Riccardi, R. Neuroprotective role of nerve growth factor in hypoxicischemic injury. From brain to skin. Arch. Ital. Biol. 2011, 149, 275-282.